🔗 Share this article

A shadow economy for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.

Experimental Drug Gaining Traction Online

The experimental drug, which is still in research studies, is being promoted by social media influencers for its supposed fat-burning properties. Followers are urged to contact these profiles privately for source information, while also receiving promotional offers.

Active Trade on Messaging Platforms

Separately, a robust trade exists on messaging services, where communities with thousands of participants share comparison images, injection guides and claims of next-day British shipping. Sellers promote the substance there before redirecting customers to WhatsApp for purchases.

Learning About Retatrutide

This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Healthcare Professionals Voice Concerns

However, doctors and pharmacists have cautions that the distribution of what is still an unapproved drug in the UK is worrisome and could lead to individuals injecting substances of uncertain source.

Some professionals stated the popularity for the experimental drug could be linked to the increasing price of approved weight loss treatments such as Mounjaro.

Regulatory Status and Enforcement

Selling retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still breach medicines, marketing, and consumer regulations, potentially leading to fines, prosecution or imprisonment.

Platform Reaction and Content Elimination

According to the social media company, the platform has removed violative content and prohibited related hashtags and query recommendations. The company stated it was committed to keeping the platform safe and investing in enhancing enforcement strategies.

Online Trading Activities

Investigations also found communities with up to nine thousand participants selling the experimental drug using the platform's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly brings up channels with thousands of members, filled with images of weight loss, positive testimonials and detailed guides for mixing or administering at residence.

Within moments of joining one group, a seller posted WhatsApp details, where most transactions take place. The vendor sent an instruction manual and guaranteed delivery within 48 hours. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None inquired about body mass, health issues or past usage.

Product Information and Costs

Inside these communities, posts show black plastic packages with postal service labels, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at residence with sterile water, or pre-filled injectors usually priced at 160 pounds for 20 milligrams. When questioned how much time a pen should be used, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for Telegram stated it regularly moderated dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are administering materials they cannot confirm. Even if the research behind this drug is valid, these online versions may not contain what they claim,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor connected the surge in interest to current price rises for authorized weight-loss drugs such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit treatments are extremely risky. You cannot know what’s contained or whether the environment they were produced in was clean,” she explained.

Her team has already encountered patients harmed by self-injection from unverified suppliers. “We understand the frustration, but purchasing from Telegram or communication platforms is taking chances with your well-being,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”

Producer Position

A representative from the pharmaceutical company said retatrutide was in third stage research studies and had not been evaluated or approved by any regulatory agency globally. “Therefore at this point no one can market [it] for personal consumption,” they said, noting that any item “falsely representing itself as a Lilly experimental substance not yet authorized … may expose users to potentially serious medical dangers”.